Human and economic burden of generalized anxiety disorder.
about
Does bright light have an anxiolytic effect? - an open trialInternet treatment for generalized anxiety disorder: a randomized controlled trial comparing clinician vs. technician assistanceCognitive bias modification for anxiety: current evidence and future directionsChildhood respiratory symptoms and mental health problems: the role of intergenerational smokingNicotine modulation of fear memories and anxiety: Implications for learning and anxiety disorders.Chronic Galphas signaling in the striatum increases anxiety-related behaviors independent of developmental effectsDual efficacy of delta opioid receptor-selective ligands for ethanol drinking and anxietyPharmacological targeting of the mammalian clock regulates sleep architecture and emotional behaviourEconomic and humanistic burden of illness in generalized anxiety disorder: an analysis of patient survey data in Europe.The Generalised Anxiety Stigma Scale (GASS): psychometric properties in a community sampleRasch model analysis of the Depression, Anxiety and Stress Scales (DASS).Use of complementary and alternative medicine in a large sample of anxiety patients.Cost-effectiveness of pregabalin versus venlafaxine in the treatment of generalized anxiety disorder: findings from a Spanish perspectiveModeling dropout from adverse event data: impact of dosing regimens across pregabalin trials in the treatment of generalized anxiety disorder.Escitalopram for older adults with generalized anxiety disorder: a randomized controlled trial.Health-related Quality of Life across the anxiety disorders: findings from a sample of primary care patientsJoint trajectories of cigarette smoking and depressive symptoms from the mid-20s to the mid-30s predicting generalized anxiety disorderQuality of life as patient-reported outcomes: principles of assessment.Multicenter, randomized, double-blind, active comparator and placebo-controlled trial of a corticotropin-releasing factor receptor-1 antagonist in generalized anxiety disorder.Evaluation of anxiolytic activity of the essential oil of the aerial part of Foeniculum vulgare Miller in miceCombining computerized home-based treatments for generalized anxiety disorder: an attention modification program and cognitive behavioral therapyPregabalin: a review of its use in adults with generalized anxiety disorder.Impairment and functioning in a sample of primary care patients with generalized anxiety disorder: results from the primary care anxiety project.Combined medication and CBT for generalized anxiety disorder with African American participants: reliability and validity of assessments and preliminary outcomesNew advances in the treatment of generalized anxiety disorder: the multimodal antidepressant vortioxetine.Disability and health-related quality of life in outpatients with generalised anxiety disorder treated in psychiatric clinics: is there still room for improvement?The role of values-consistent behavior in generalized anxiety disorder.Childhood maltreatment is associated with larger left thalamic gray matter volume in adolescents with generalized anxiety disorderClinical and economic outcomes of adjunctive therapy with pregabalin or usual care in generalized anxiety disorder patients with partial response to selective serotonin reuptake inhibitorsWhite matter abnormalities in adolescents with generalized anxiety disorder: a diffusion tensor imaging study.Elevated tph2 mRNA expression in a rat model of chronic anxiety.Reliability and validity of the Portuguese version of the Generalized Anxiety Disorder (GAD-7) scale.Comparative effectiveness and costs of generic and brand-name gabapentin and venlafaxine in patients with neuropathic pain or generalized anxiety disorder in SpainSerotonin transporter gene polymorphism (5-HTTLPR) L allele interacts with stress to increase anxiety symptoms in Chinese adolescents: a multiwave longitudinal study.Generalized anxiety disorder in primary care: mental health services use and treatment adequacyPregabalin effects on neural response to emotional faces.Perceived Emotion Control Moderates the Relationship between Neuroticism and Generalized Anxiety DisorderCognitive risk profiles for anxiety disorders in a high-risk populationAssessment of anxiety and depression in primary care: value of a four-item questionnaireInteraction between serotonin transporter polymorphism (5-HTTLPR) and stressful life events in adolescents' trajectories of anxious/depressed symptoms.
P2860
Q21260272-1D774114-732D-4759-B003-4F1713E14E83Q21562198-9ACA2180-C6E6-4FB5-980D-26B616998533Q24594943-8164B1A0-2BCD-4770-9C4B-30D65048283FQ28387626-109561B4-046A-48BF-8D80-A42F3EEBF3F4Q30372354-8AFBE184-C462-4A40-A0EB-44B658D8558CQ30488915-9D2A595A-CC45-485C-B2CF-35A1D5D75111Q30497060-8D58A34B-1776-41B0-8045-0178F6698213Q30657215-7D7AF590-E877-406C-A029-1DC18A99102AQ30799939-6F3369CE-50CE-4C14-91D0-3E40E676FF87Q31042005-52A95FBB-C21A-4E58-B004-8A3C81DDB44FQ33441923-27922A6C-99A8-4EB9-BA6F-81491A1538A7Q33583404-FB1448E9-D07D-4BBD-AD3B-8592CFF8722FQ33629375-5BED86FE-E095-4C5D-A5AB-71340454BF5BQ33642622-01B7241A-73C4-414F-B24D-EAC372FB72FEQ33734249-F7592BDD-0432-403E-AEE7-216C479DADB1Q33876041-C087F46D-5B8C-4DD1-BDC6-29471B1C9EB8Q33887745-035C3780-EE9F-4CFD-803E-01FA5D99A76BQ34074648-A2DDA257-7814-4546-BCC0-F759716D681FQ34114364-35C49D67-41FB-422F-9DFE-5365305467C9Q34143912-A7FD60A8-28C0-4DAF-8CBB-7CCD803587A5Q34281469-31485A64-DA7D-4C8A-BFF9-038E2DE3D432Q34434641-A5DD3DA9-98D1-4990-B8C7-FA4659B3D726Q34516239-F750B50C-8997-4D72-8788-19E07AAE649BQ34663308-181E856D-C9FC-4426-BE87-79BCDCC04085Q34676776-9118618A-95B3-451E-B244-B7D3B13A42F4Q34722479-BFFE5BA3-A854-4BED-A909-54D8A41A4975Q34917926-D0E1C69B-129C-4AEB-8EC7-952949B71856Q34950846-3E999D3C-5053-444C-826D-D20278B41C36Q35021417-4EE656AA-FF87-4211-B540-68DBC3D8055FQ35094444-ED6511AB-D6A6-4ABA-938B-9601008F226FQ35552464-FDC8DEE5-46E6-421E-BD3C-58F160A835F7Q35583957-9C343C8D-73D4-4547-BECC-6B6085C6D237Q35703502-3FB98608-A9A7-46E5-8AD3-C52F6CA79B55Q35807706-3E79ADD1-5594-45D6-810F-1EB009FDC83CQ35817586-BEF06A76-A48B-45F7-BC5E-44DDF669CFDBQ35855502-3FBC847C-E188-4E81-87A9-E667844AE678Q35903814-8A075A36-3B48-4FCB-9E4D-E3D507E036E4Q35988562-730AEADC-B687-4048-A4A4-D9D47DA384EFQ36051543-10BDE1D8-C183-4E57-96F0-2DB2116617DAQ36113243-6D024C5E-9B03-4EC0-952D-704D8999C23B
P2860
Human and economic burden of generalized anxiety disorder.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Human and economic burden of generalized anxiety disorder.
@ast
Human and economic burden of generalized anxiety disorder.
@en
type
label
Human and economic burden of generalized anxiety disorder.
@ast
Human and economic burden of generalized anxiety disorder.
@en
prefLabel
Human and economic burden of generalized anxiety disorder.
@ast
Human and economic burden of generalized anxiety disorder.
@en
P2860
P356
P1476
Human and economic burden of generalized anxiety disorder.
@en
P2093
Deborah L Hoffman
Ellen M Dukes
P2860
P356
10.1002/DA.20257
P577
2008-01-01T00:00:00Z